We are live on ! Find out more
NDRM

NeuroDerm Ltd. Ordinary Shares
NDRM

Delisted

NDRM was delisted on the 17th of October, 2017.

Back to rankings

5 hedge funds and large institutions have $1.3M invested in NeuroDerm Ltd. Ordinary Shares in 2017 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 76 closing their positions.

New
Increased
Maintained
Reduced
Closed

94% less funds holding

Funds holding: 81 → 5 (-76)

99% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 76

100% less capital invested

Capital invested by funds: $501M → $1.3M (-$499M)

100% less funds holding in top 10

Funds holding in top 10: 3 → 0 (-3)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
5
Holders Change
-76
Holders Change %
-93.83%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
76
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
FWM
Focused Wealth Management
New York
+$1.25K

Top Sellers

Rank Fund Capital Flow
1
AA
AQR Arbitrage
Connecticut
-$53.3M
2
SAM
Sandell Asset Management
New York
-$43.9M
3
OP
Omni Partners
United Kingdom
-$43.4M
4
JP Morgan Chase
JP Morgan Chase
New York
-$28.8M
5
OAM
Oxford Asset Management
United Kingdom
-$22.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
VOAM
1
Vertex One Asset Management
British Columbia, Canada
$1.13M – – –
OTC
2
Opera Trading Capital
France
$141K – – –
IA
3
IFP Advisors
Florida
$23K -$40.8K -1,050 -64%
FWM
4
Focused Wealth Management
New York
$1K +$1.25K +32 New
AA
5
AQR Arbitrage
Connecticut
– -$53.3M -1,370,876 Closed
SAM
6
Sandell Asset Management
New York
– -$43.9M -1,128,950 Closed
OP
7
Omni Partners
United Kingdom
– -$43.4M -1,116,596 Closed
JP Morgan Chase
8
JP Morgan Chase
New York
– -$28.8M -739,334 Closed
OAM
9
Oxford Asset Management
United Kingdom
– -$22.9M -588,700 Closed
BBA
10
Baker Bros. Advisors
New York
– -$22.2M -571,667 Closed
Allianz Asset Management
11
Allianz Asset Management
Germany
– -$21.1M -541,544 Closed
CFIC
12
City Financial Investment Company
United Kingdom
– -$20.9M -537,748 Closed
WIC
13
Water Island Capital
New York
– -$17.8M -458,400 Closed
FTCM
14
First Trust Capital Management
Illinois
– -$16.4M -422,771 Closed
Goldman Sachs
15
Goldman Sachs
New York
– -$14.4M -369,029 Closed
GCIA
16
Gabelli & Co Investment Advisers
New York
– -$14.2M -364,548 Closed
Citigroup
17
Citigroup
New York
– -$14.1M -362,703 Closed
ACH
18
ArrowMark Colorado Holdings
Colorado
– -$12.7M -325,780 Closed
GF
19
Gabelli Funds
New York
– -$10M -257,710 Closed
RSCM
20
Rock Springs Capital Management
Maryland
– -$9.25M -237,700 Closed
SCM
21
Scopia Capital Management
New York
– -$7.99M -205,358 Closed
GCL
22
Glazer Capital LLC
New York
– -$7.97M -205,000 Closed
TCSAM
23
Tyrus Capital S.A.M.
Monaco
– -$7.21M -185,300 Closed
BlackRock
24
BlackRock
New York
– -$6.84M -175,858 Closed
COPPSERS
25
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
– -$6.34M -163,084 Closed
1
2 3 4

NDRM Hedge Fund Activity: Q4 2017 in Review

5 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in NeuroDerm Ltd. Ordinary Shares (NDRM) for Q4 2017, worth a combined $1.3M — down 100% from $501M a quarter earlier.

Sellers outnumbered buyers: 76 funds closed out of NDRM and 1 opened new positions — a net loss of 75 holders — while 1 trimmed existing stakes and 0 added.

The largest buyer was Focused Wealth Management, opening a new position worth an estimated $1.25K. The largest seller was AQR Arbitrage, exiting entirely with an estimated $53.3M sold.

  • 5 institutional investors held NeuroDerm Ltd. Ordinary Shares (NDRM) as of Q4 2017, down from 81 in Q3 2017.
  • Funds reported $1.3M of NeuroDerm Ltd. Ordinary Shares stock for Q4 2017, down 100% quarter-over-quarter.
  • 1 fund opened new NeuroDerm Ltd. Ordinary Shares positions in Q4 2017 and 76 closed out, a net change of -75 holders.
  • The largest NeuroDerm Ltd. Ordinary Shares buyer in Q4 2017 was Focused Wealth Management, an estimated $1.25K added.
  • The largest NeuroDerm Ltd. Ordinary Shares seller in Q4 2017 was AQR Arbitrage, an estimated $53.3M sold.

Based on aggregated 13F filings for Q4 2017.